Nanog: A potential biomarker for liver metastasis of colorectal cancer

Digestive Diseases and Sciences

Volumn 57, Issue 9, 2012, Pages 2340-2346

  Xu, Feng ^a   Dai, Chaoliu ^a   Zhang, Rui ^b   Zhao, Yang ^a   Peng, Songlin ^a   Jia, Changjun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Colorectal neoplasms; NANOG protein; Neoplasm metastasis; Stem cell

Indexed keywords

CD133 ANTIGEN; TRANSCRIPTION FACTOR NANOG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; COLORECTAL CANCER; CORRELATION ANALYSIS; FEMALE; FGF5 GENE; GATA6 GENE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NANOG GENE; NESTIN GENE; NODAL GENE; OLIG2 GENE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADICAL RESECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

ANTIGENS, CD; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; LYMPH NODES; ODDS RATIO; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866412676     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2182-8     Document Type: Article

References (19)

1. Li Y, Laterra J. Cancer stem cells: distinct entities or dynamically regulated phenotypes? Cancer Res. 2012;72:576-580.
2. Chu JE, Allan AL. The role of cancer stem cells in the organ tropism of breast cancer metastasis: a mechanistic balance between the seed and the soil? Int J Breast Cancer. 2012;2012:209748.
3. Galizia G, Gemei M, Del Vecchio L, et al. Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer. Arch Surg. 2012;147:18-24.
4. Shimada R, Iinuma H, Akahane. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients. Oncol Rep. 2012;27:947-953.
5. Gisina AM, Lupatov AY, Karalkin PA, et al. Detection of minor subpopulations of colorectal adenocarcinoma cells expressing cancer stem cell markers. Bull Exp Biol Med. 2011;151:234-238.
6. + stem cell-like human colon cancer cells. Biochem Biophys Res Commun. 2011;416:246-251.
7. Ding Q, Chang CJ, Xie X, et al. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest. 2011;121:4526-4536.
8. Ezeh UI, Turek PJ, Reijo RA, Clark AT. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer. 2005;104:2255-2265. (Pubitemid 41579973)
9. Liu C, Cao X, Zhang Y, Xu H, Zhang R, Wu Y, Lu P, Jin F. Co-expression of Oct-4 and Nestin in human breast cancers. Mol Biol Rep. 2012;39:5875-5881
10. Liu CG, Lu Y, Wang BB, et al. Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann Surg. 2011;253:1165-1171.
11. Pan G, Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res. 2007;17:42-49. (Pubitemid 46096423)
12. Ratto C, Ricci R. Potential pitfalls concerning colorectal cancer classification in the seventh edition of the AJCC cancer staging manual. Dis Colon Rectum. 2011;54:e232.
13. Khuda II, Koide N, Noman AS, et al. Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling. Immunology. 2009;128:e700-e706.
14. He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene. 2011. (Epub ahead of print). doi: 10.1038/onc.2011.500.
15. Liu C, Chen B, Zhu J, et al. Clinical implications for nestin protein expression in breast cancer. Cancer Sci. 2010;101:815-819.
16. Vermeulen L, de Sousa E, Melo F, Richel DJ, Medema JP. The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol. 2012;13:e83-e89.
17. Moon JH, Kwon S, Jun EK, et al. Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells. Biochem Biophys Res Commun. 2011;412:175-181.
18. Meng HM, Zheng P, Wang XY, Liu C, Sui HM, Wu SJ, Zhou J, Ding YQ, Li JM. Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer. Cancer Biol Ther. 2010;9:4.
19. Bourguignon LY, Earle C, Wong G, Spevak CC, Krueger K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene. 2012;31:149-160.